Processa Pharmaceuticals Competitors and Similar CompaniesClear all
Processa Pharmaceuticals's competitors and similar companies include Nektar Therapeutics and Prolong Pharmaceuticals.
 Processa Pharmaceuticals Processa Pharmaceuticals (formerly Heatwurx) is a company focused on developing treatments for patients with an unmet medical need. |  Prolong Pharmaceuticals Prolong Pharmaceuticals is a company providing SANGUINATE, a medication focusing on treating sickle cell disease and other disorders caused by anemia, hypoxia, or ischemia. | ||
Founding Date | Founding Date 2017 | Founding Date 1990 | Founding Date 2005 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Hanover, US HQ | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations South Plainfield, US HQ |
Employees | Employees 1033% decrease | Employees 61821% increase | Employees 225% increase |
Valuation ($) | Valuation ($) 4.4 m | Valuation ($) 233.8 m | Valuation ($) N/A |
Financial | |||
Net income | Net income ($13.6m) (FY, 2025) | Net income ($164.1m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 45m | Total funding raised $ 30m |
For sources of this data, please see the company profile
View Company Profiles
Nektar Therapeutics
HQ
San Francisco, US
Employees
618↑ 21% increase
Nektar Therapeutics is a stage-clinical biopharmaceutical company.
View companyProlong Pharmaceuticals
HQ
South Plainfield, US
Employees
22↑ 5% increase
Prolong Pharmaceuticals is a company providing SANGUINATE, a medication focusing on treating sickle cell disease and other disorders caused by anemia, hypoxia, or ischemia.
View company